Skip to main content

Advertisement

SpringerLink
Log in

No Association Between p21 Gene rs1059234 Polymorphisms and Risk of Endometrial Cancer Among Han Women in Northeast China

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Objective of the study is to find the association between p21 rs1059234 polymorphisms and endometrial cancer in Han women from Northeast China. Genotyping of rs1059234 in the p21 gene was performed by sequencing and PCR-restriction fragment length polymorphism (PCR–RFLP) of peripheral blood samples in 263 endometrial cancer patients (case group) and 315 healthy subjects (control group). C allele frequency of rs1059234 was significantly increased in patients of the case group when compared with that in the control group (P = 0.039). The CC genotype frequency of rs1059234 was also significantly increased in patients of case group (0.335, vs. 0.219, P = 0.045). CC genotype increased the risk of endometrial cancer (OR = 1.589, 95 %CI: 1.010–2.502). However, after corrected with regression analysis, the CC genotype did not increase the risk of endometrial cancer (OR = 1.623, 95 % CI: 0.720–3.659, P = 0.243). Our study demonstrates that in Han women from Northeast China, there is no association between rs1059234 polymorphism of p21 gene and risk of endometrial cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Bibliography

  1. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74–108.

    Google Scholar 

  2. Bokhman, J. V. (1983). Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology, 15, 10–17.

    Article  CAS  PubMed  Google Scholar 

  3. Ashton, K. A., Proietto, A., Otton, G., Symonds, I., McEvoy, M., et al. (2009). Estrogen receptor polymorphisms and the risk of endometrial cancer. BJOG, 116, 1053–1061.

    Article  CAS  PubMed  Google Scholar 

  4. Sasaki, M., Tanaka, Y., Kaneuchi, M., Sakuragi, N., & Dahiya, R. (2003). CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Research, 63, 3913–3918.

    CAS  PubMed  Google Scholar 

  5. Chen, X., Xiang, Y. B., Long, J. R., Cai, H., Cai, Q., et al. (2012). Genetic polymorphisms in obesity-related genes and endometrial cancer risk. Cancer, 118, 3356–3364.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Cai, H., Xiang, Y. B., Qu, S., Long, J., Cai, Q., et al. (2011). Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women. American Journal of Epidemiology, 173, 1263–1271.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Ashton, K. A., Proietto, A., Otton, G., Symonds, I., McEvoy, M., et al. (2008). The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor. BMC Cancer, 8, 272.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., & Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805–816.

    Article  CAS  PubMed  Google Scholar 

  9. Gartel, A. L., Serfas, M. S., & Tyner, A. L. (1996). p21–negative regulator of the cell cycle. Proceedings of the Society for Experimental Biology and Medicine, 213, 138–149.

    Article  CAS  PubMed  Google Scholar 

  10. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., et al. (1993). p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701–704.

    Article  CAS  PubMed  Google Scholar 

  11. Wang, N., Wang, S., Zhang, Q., Lu, Y., Wei, H., et al. (2012). Association of p21 SNPs and risk of cervical cancer among Chinese women. BMC Cancer, 12, 589.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Roh, J. W., Kim, J. W., Park, N. H., Song, Y. S., Park, I. A., et al. (2004). p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. Gynecologic Oncology, 93, 499–505.

    Article  CAS  PubMed  Google Scholar 

  13. Chen, W. C., Wu, H. C., Hsu, C. D., Chen, H. Y., & Tsai, F. J. (2002). p21 gene codon 31 polymorphism is associated with bladder cancer. Urologic Oncology, 7, 63–66.

    Article  CAS  PubMed  Google Scholar 

  14. Keshava, C., Frye, B. L., Wolff, M. S., McCanlies, E. C., & Weston, A. (2002). Waf-1 (p21) and p53 polymorphisms in breast cancer. Cancer Epidemiology Biomarkers and Prevention, 11, 127–130.

    CAS  Google Scholar 

  15. Huang, S. P., Wu, W. J., Chang, W. S., Wu, M. T., Chen, Y. Y., et al. (2004). p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer. Cancer Epidemiology Biomarkers and Prevention, 13, 2217–2224.

    CAS  Google Scholar 

  16. Cacina, C., Yaylim-Eraltan, I., Arikan, S., Saglam, E. K., Zeybek, U., et al. (2010). Association between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis. In Vivo, 24, 179–183.

    CAS  PubMed  Google Scholar 

  17. Li, G., Liu, Z., Sturgis, E. M., Shi, Q., Chamberlain, R. M., et al. (2005). Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 26, 1596–1602.

    Article  CAS  PubMed  Google Scholar 

  18. Facher, E. A., Becich, M. J., Deka, A., & Law, J. C. (1997). Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene. Cancer, 79, 2424–2429.

    Article  CAS  PubMed  Google Scholar 

  19. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817–825.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have on conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, 36 Sanhao Road, Heping District, Shenyang, 110004, Liaoning, China

    Duo Yin, Yan Jiang, Shulan Zhang, Ning Wang, Yanming Lu, Heng Wei, Naichen Huo, Qian Xiao & Yangling Ou

Authors
  1. Duo Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shulan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ning Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yanming Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Heng Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Naichen Huo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qian Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yangling Ou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shulan Zhang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yin, D., Jiang, Y., Zhang, S. et al. No Association Between p21 Gene rs1059234 Polymorphisms and Risk of Endometrial Cancer Among Han Women in Northeast China. Cell Biochem Biophys 71, 167–171 (2015). https://doi.org/10.1007/s12013-014-0180-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-0180-5

Keywords

Search

Navigation